Resignation of CEO & Managing Director

Resignation of CEO & Managing Director

The Company CEO and Managing Director, Elmo De Alwis has today tendered his resignation to the Company as Chief Executive Officer and Managing Director, which the Board has accepted.


Mr De Alwis has agreed to continue in the role until the Board has identified and appointed his replacement. That process is under way.

Chairman John Stocker said "on behalf of the Board, I sincerely thank Elmo for his hard work and dedication throughout his 33 years with the business. Over this period, he has made a substantial contribution to the organisation. "The Company will advise further on the outcome of its search as soon as it is completed.
Sue Morgan-Dethick
GENERAL COUNSEL AND COMPANY SECRETARY
SIGMA PHARMACEUTICALS LIMITED
ABN 15 088 417 403
Locked Bag 268 (96 Merrindale Drive) Croydon Victoria 3136 Australia
Telephone: (+61-3) 03-9839 2800 Facsimile: (+61-3) 03-9839 2811

Suggested Articles

Almirall is pulling the trigger on an option to advance Dermira's lebrikizumab in Europe, a program it reckons could rake in €450 million.

Acer Therapeutics’ stock plummeted more than 78% premarket this morning on news that the FDA had rejected approval of its drug Edsivo (celiprolol).

The latest setback prompted Novartis-partnered Conatus to lay off 40% of its staff and begin looking for strategic alternatives.